Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 132061 - 132070 of 132111 results

First page
Previous page
Next page
Next page

INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

GB6ADZ2ASN

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

Class:

CONCEPT

INFLUENZA A VIRUS A/HONG KONG/4801/2014 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

2I1EOL437M

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce88cc84-b4ed-4d59-8897-10cb53dc2edf

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce88cc84-b4ed-4d59-8897-10cb53dc2edf

Class:

CONCEPT

SUNBURST ORANGE DANIO TRANSGENIC WHOLE (YZF2010 RDNA CONSTRUCT)

WFG4Y8F8VJ

Status:

Possibly Marketed Outside US

Source:

Sunburst Orange Danio by GloFish LLC

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=172f01c1-96aa-43a1-a864-1b655b11f610

First approved in 2013

Source:

Sunburst Orange Danio by GloFish LLC

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=172f01c1-96aa-43a1-a864-1b655b11f610

Class:

CONCEPT

GALACTIC PURPLE TETRA TRANSGENIC WHOLE (PT2013 RDNA CONSTRUCT)

GJW1798WZF

Status:

Possibly Marketed Outside US

Source:

GALACTIC PURPLE TETRA by GloFish LLC

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf6cdc6c-fff8-4626-8053-af25184afcc1

First approved in 2013

Source:

GALACTIC PURPLE TETRA by GloFish LLC

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf6cdc6c-fff8-4626-8053-af25184afcc1

Class:

CONCEPT

MOONRISE PINK TETRA TRANSGENIC WHOLE (RT2012A RDNA CONSTRUCT)

5Z2K9J0SX7

Status:

Possibly Marketed Outside US

Source:

Moonrise Pink Tetra by GloFish LLC

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a68e8e2e-e97c-43ec-a541-0db63dadaaa3

First approved in 2013

Source:

Moonrise Pink Tetra by GloFish LLC

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a68e8e2e-e97c-43ec-a541-0db63dadaaa3

Class:

CONCEPT

STEARYL/OCTYLDODECYL CITRATE CROSSPOLYMER

PN88NW0KPK

Status:

Possibly Marketed Outside US

Source:

21 CFR 352

(2017)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f0f2707-7fd6-491d-a928-7d420b17da80

First approved in 2013

Source:

21 CFR 352

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=247aae3d-1845-4dd8-b774-b9e8214809a2

Class:

CONCEPT

INFLUENZA A VIRUS A/BRISBANE/02/2018 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

DC4ELG1BFZ

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

Class:

CONCEPT

INFLUENZA A VIRUS A/KANSAS/14/2017 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

I282A48KKK

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

Class:

CONCEPT

INFLUENZA B VIRUS B/MARYLAND/15/2016 RECOMBINANT HEMAGGLUTININ ANTIGEN

Z48BXE2O2P

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67de8652-2e5a-4d18-aee9-d9b789ccfe46

Class:

CONCEPT

INFLUENZA A VIRUS A/MICHIGAN/45/2015 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

69H0YJ871T

Status:

Possibly Marketed Outside US

Source:

BLA125285

(2013)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce88cc84-b4ed-4d59-8897-10cb53dc2edf

First approved in 2013

Source:

BLA125285

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce88cc84-b4ed-4d59-8897-10cb53dc2edf

Class:

CONCEPT

Concept

INFLUENZA A VIRUS A/WISCONSIN/588/2019 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/HONG KONG/4801/2014 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

SUNBURST ORANGE DANIO TRANSGENIC WHOLE (YZF2010 RDNA CONSTRUCT)

Concept

GALACTIC PURPLE TETRA TRANSGENIC WHOLE (PT2013 RDNA CONSTRUCT)

Concept

MOONRISE PINK TETRA TRANSGENIC WHOLE (RT2012A RDNA CONSTRUCT)

Concept

STEARYL/OCTYLDODECYL CITRATE CROSSPOLYMER

Concept

INFLUENZA A VIRUS A/BRISBANE/02/2018 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/KANSAS/14/2017 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA B VIRUS B/MARYLAND/15/2016 RECOMBINANT HEMAGGLUTININ ANTIGEN

Concept

INFLUENZA A VIRUS A/MICHIGAN/45/2015 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN

Showing 132061 - 132070 of 132111 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1